OTC · Biotechnology

Comera Life Sciences Holdings, Inc. (CMRA) Stock

$0.00 OTC: CMRA Healthcare

Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies.

Valuation

MetricValue
Price$0.00
Market Cap$3074
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-1.76
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE300.00%
ROA-450.00%
ROCE898.94%
Gross Margin-1200.00%
Operating Margin-1200.00%
Net Margin-1800.00%
Debt/Equity-0.17
Current Ratio0.60

Annual Financials (USD)

Metric202020212022
Revenue$0$0$1.0M
Operating Profit$-2.0M$-6.0M$-12.0M
Net Profit$-2.0M$-5.0M$-18.0M
EPS$-0.11$-0.29$-1.76
Op Margin-480.3%-1730.8%-1890.7%

Balance Sheet (USD)

Metric202020212022
Total Assets$1.0M$7.0M$4.0M
Total Liabilities$0$22.0M$10.0M
Cash$0$7.0M$0
Borrowings$0$0$1.0M

Cash Flow (USD)

Metric202020212022
Operating Cash Flow$-2.0M$-4.0M$-10.0M
Investing Cash Flow$0$0$0
Financing Cash Flow$0$0$5.0M
Net Cash Flow$0$6.0M$-5.0M
Free Cash Flow$-2.0M$-4.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.02
FCF Yield-318815.13%
Quick Ratio0.61
Interest Coverage-587.02
Return 1Y-50.00%
Return 3Y-99.98%
Return 5Y—

Ownership

Insiders Held62.18%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Vanguard Group Inc44,0982023-09-30
State Street Corporation29,6002023-09-30
Citadel Advisors Llc17,4582023-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTHAnthera Pharmaceuticals, Inc. $0.00 — 0.00 $2618 0.00%
COTQFCotinga Pharmaceuticals Inc. $0.00 — 0.00 $2199 0.00%
FPMIFluoroPharma Medical, Inc. $0.00 — 0.00 $6852 0.00%
GBIMGlobeImmune, Inc. $0.00 — 0.00 — 0.00%
NLVVFNew Leaf Ventures Inc $0.00 — -0.25 $2980 0.00%

About Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platform, engineered to transform intravenous (IV) biologic drugs into more convenient subcutaneous (SQ) injectable forms. Currently, the company is progressing two main product candidates: CLS-001, an early-stage "biobetter" designed to treat inflammatory bowel conditions like Crohn's and Ulcerative Colitis, and CLS-002, another preclinical biobetter aimed at diverse oncology indications. Established in 2014, Comera Life Sciences is headquartered in Woburn, Massachusetts.

Comera Life Sciences Holdings, Inc. (CMRA) stock trades at $0.00 with a market capitalization of $3074. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Comera Life Sciences Holdings, Inc. generates a return on equity (ROE) of 300.00% — well above the market average, a sign of a high-quality business, return on capital employed of 898.94%, an operating margin of -1200.00%, a net profit margin of -1800.00%.

Official website: comeralifesciences.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides